CEREVEL THERAPEUTICS HOLDINGS INCCEREVEL THERAPEUTICS HOLDINGS INCCEREVEL THERAPEUTICS HOLDINGS INC

CEREVEL THERAPEUTICS HOLDINGS INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪7.18 B‬EUR
−2.42EUR
‪−392.16 M‬EUR
‪87.15 M‬
Beta (1Y)
1.38

About Cerevel Therapeutics Holdings, Inc.

CEO
Ronald C. Renaud
Headquarters
Cambridge
Employees (FY)
334
Founded
2018
Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. Its product candidates include CVL-231, Darigabat, Tavapadon, CVL-871, and CVL-936. The company was founded in 2018 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 673 is 39.40 EUR — it hasn't changed in the past 24 hours. Watch CEREVEL THERAPEUTICS HOLDINGS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange CEREVEL THERAPEUTICS HOLDINGS INC stocks are traded under the ticker 673.
CEREVEL THERAPEUTICS HOLDINGS INC is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
673 stock is 0% volatile and has beta coefficient of 1.38. Track CEREVEL THERAPEUTICS HOLDINGS INC stock price on the chart and check out the list of the most volatile stocks — is CEREVEL THERAPEUTICS HOLDINGS INC there?
673 earnings for the last quarter are −0.69 EUR per share, whereas the estimation was −0.61 EUR resulting in a −14.37% surprise. The estimated earnings for the next quarter are −0.59 EUR per share. See more details about CEREVEL THERAPEUTICS HOLDINGS INC earnings.
Yes, you can track CEREVEL THERAPEUTICS HOLDINGS INC financials in yearly and quarterly reports right on TradingView.
673 stock has fallen by 1.01% compared to the previous week, the month change is a 1.03% rise, over the last year CEREVEL THERAPEUTICS HOLDINGS INC has showed a 34.93% increase.
673 net income for the last quarter is ‪−120.19 M‬ EUR, while the quarter before that showed ‪−91.16 M‬ EUR of net income which accounts for −31.85% change. Track more CEREVEL THERAPEUTICS HOLDINGS INC financial stats to get the full picture.
Today CEREVEL THERAPEUTICS HOLDINGS INC has the market capitalization of ‪7.18 B‬, it has decreased by 0.84% over the last week.
No, 673 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 673 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CEREVEL THERAPEUTICS HOLDINGS INC stock right from TradingView charts — choose your broker and connect to your account.
673 reached its all-time high on Feb 15, 2024 with the price of 40.20 EUR, and its all-time low was 18.80 EUR and was reached on Aug 7, 2023. View more price dynamics on 673 chart.
See other stocks reaching their highest and lowest prices.
As of May 8, 2024, the company has 334.00 employees. See our rating of the largest employees — is CEREVEL THERAPEUTICS HOLDINGS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CEREVEL THERAPEUTICS HOLDINGS INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CEREVEL THERAPEUTICS HOLDINGS INC stock shows the buy signal. See more of CEREVEL THERAPEUTICS HOLDINGS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CEREVEL THERAPEUTICS HOLDINGS INC future price: according to them, 673 price has a max estimate of 41.98 EUR and a min estimate of 41.98 EUR. Watch 673 chart and read a more detailed CEREVEL THERAPEUTICS HOLDINGS INC stock forecast: see what analysts think of CEREVEL THERAPEUTICS HOLDINGS INC and suggest that you do with its stocks.